Interestingly, certain bacteria are being investigated for their potential in cancer therapy. For instance, genetically engineered strains of Salmonella and Clostridium have shown promise in preclinical studies. These bacteria can selectively target and destroy tumor cells while sparing normal tissues. Moreover, some bacterial products, like L-asparaginase, are already used in the treatment of specific cancers, such as leukemia.
